Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.15 USD
-0.10 (-3.08%)
Updated Sep 6, 2024 03:59 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Brokerage Reports
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 141 - 156 ( 156 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Signs of Recovery But Increasing Taxes Payable Pose a Challenge for H2/22
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Consumer Access Key - Opening More Retail Licenses
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Deferred Taxes, Another Low "Cost" Cash Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
1Q22 In-Line As Expected, Set Up to Drive Leading Margins, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
NJ Adult-Use Cannabis Update: New Recreational Stores Added to Begin Sales
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
1Q22 Preview, NJ Investment/ Positioning to Drive Growth
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
4Q21 Messy with GAAP Transition, Still Best-in-Class, Lower PT to $26 - Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Q421 Results Show Larger than Expected Margin Blip Which will Persist into Q122, Upwards from Then, $240M Est. Operating Cashflow in 2022
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: CAOA Federal Reform Update and Alcohol Tier Model in Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Consumer Weekly ReHash: Assessing 4Q21 Reports & Resetting 2022 Guidance/Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Want Cashflow, NJ/CT, a Solid Balance Sheet, and a Discounted Valuation? Verano?s Got It, So Get into Verano. Returning Top Pick
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Unclassified
4Q21 MSO Preview: Expect Flat Results & Tempered ''22 Guidance Outlooks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S